Pharmaceutical

InSilicoTrials and Axoltis to develop drugs for neurological disorders

InSilicoTrials has entered a partnership with Axoltis Pharma for the advancement of therapeutic solutions for neurological disorders.

Jul 29, 2023 - 20:00
InSilicoTrials and Axoltis to develop drugs for neurological disorders
InSilicoTrials has entered a partnership with Axoltis Pharma for the advancement of therapeutic solutions for neurological disorders.
Read the original article

Tags:

Previous Article

Bristol Myers Squibb reports 6% drop in Q2 2023 revenues

Next Article

Gilead gains EC approval for metastatic breast cancer drug Trodelvy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: How Long Island became the ‘eugenics capital of the world’

Listen: How Long Island became the ‘eugenics capital of...

Aug 15, 2023

STAT+: Bristol ‘take-under’ of Mirati is not so great for biotech, but company’s new cancer target has potential

STAT+: Bristol ‘take-under’ of Mirati is not so great f...

Oct 10, 2023

STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more

STAT+: Pharmalittle: We’re reading about Wegovy approve...

Mar 12, 2024